MA54942A - Composition de vaccin contre la grippe atténué vivant et procédé de préparation associé - Google Patents
Composition de vaccin contre la grippe atténué vivant et procédé de préparation associéInfo
- Publication number
- MA54942A MA54942A MA054942A MA54942A MA54942A MA 54942 A MA54942 A MA 54942A MA 054942 A MA054942 A MA 054942A MA 54942 A MA54942 A MA 54942A MA 54942 A MA54942 A MA 54942A
- Authority
- MA
- Morocco
- Prior art keywords
- preparing
- composition
- same
- live attenuated
- influenza vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201921006071 | 2019-02-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA54942A true MA54942A (fr) | 2021-12-22 |
Family
ID=69740470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA054942A MA54942A (fr) | 2019-02-15 | 2020-02-07 | Composition de vaccin contre la grippe atténué vivant et procédé de préparation associé |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20220211837A1 (fr) |
| EP (1) | EP3924052A1 (fr) |
| JP (1) | JP2022520443A (fr) |
| KR (1) | KR20210129073A (fr) |
| CN (1) | CN113646047A (fr) |
| AR (1) | AR119691A1 (fr) |
| AU (1) | AU2020222113A1 (fr) |
| BR (1) | BR112021016059A2 (fr) |
| CA (1) | CA3130036A1 (fr) |
| CL (1) | CL2021002111A1 (fr) |
| CO (1) | CO2021010751A2 (fr) |
| IL (1) | IL285526A (fr) |
| JO (1) | JOP20200037A1 (fr) |
| MA (1) | MA54942A (fr) |
| MX (1) | MX2021009837A (fr) |
| PE (1) | PE20212322A1 (fr) |
| SG (1) | SG11202108766RA (fr) |
| TW (1) | TW202045205A (fr) |
| UY (1) | UY38587A (fr) |
| WO (1) | WO2020165912A1 (fr) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE376825T1 (de) * | 1999-09-24 | 2007-11-15 | Glaxosmithkline Biolog Sa | Influenzavirus-impfstoffzusammensetzung zur nasalen anwendung |
| AU2004263813B8 (en) * | 2003-02-25 | 2008-09-11 | Medimmune, Llc | Methods of producing influenza vaccine compositions |
| KR101376889B1 (ko) * | 2004-10-06 | 2014-03-25 | 메디뮨 엘엘씨 | 냉장 온도 안정성 인플루엔자 백신 조성물 |
| AU2009296701B2 (en) * | 2008-09-24 | 2015-02-19 | Medimmune, Llc | Methods for cultivating cells, propagating and purifying viruses |
| ES2874817T3 (es) * | 2010-04-15 | 2021-11-05 | Shin Nippon Biomedical Laboratories Ltd | Procedimiento para generar una formulación de vacuna en polvo seco para suministro intranasal |
| TWI670085B (zh) * | 2014-02-19 | 2019-09-01 | 荷蘭商英特威國際公司 | 液體穩定之豬病毒疫苗 |
| WO2017047089A1 (fr) * | 2015-09-16 | 2017-03-23 | Shin Nippon Biomedical Laboratories, Ltd. | Compositions vaccinales |
| EP3655000A4 (fr) * | 2017-07-11 | 2021-07-14 | Universal Stabilization Technologies, Inc. | Procédé de conservation de produits biopharmaceutiques |
-
2020
- 2020-02-07 AU AU2020222113A patent/AU2020222113A1/en active Pending
- 2020-02-07 CA CA3130036A patent/CA3130036A1/fr active Pending
- 2020-02-07 KR KR1020217027060A patent/KR20210129073A/ko active Search and Examination
- 2020-02-07 JP JP2021547436A patent/JP2022520443A/ja active Pending
- 2020-02-07 EP EP20708683.6A patent/EP3924052A1/fr active Pending
- 2020-02-07 US US17/429,965 patent/US20220211837A1/en active Pending
- 2020-02-07 CN CN202080024926.8A patent/CN113646047A/zh active Pending
- 2020-02-07 BR BR112021016059-0A patent/BR112021016059A2/pt unknown
- 2020-02-07 WO PCT/IN2020/050121 patent/WO2020165912A1/fr active Application Filing
- 2020-02-07 MX MX2021009837A patent/MX2021009837A/es unknown
- 2020-02-07 MA MA054942A patent/MA54942A/fr unknown
- 2020-02-07 SG SG11202108766RA patent/SG11202108766RA/en unknown
- 2020-02-07 PE PE2021001342A patent/PE20212322A1/es unknown
- 2020-02-14 UY UY0001038587A patent/UY38587A/es unknown
- 2020-02-14 AR ARP200100405A patent/AR119691A1/es unknown
- 2020-02-14 TW TW109104708A patent/TW202045205A/zh unknown
- 2020-02-16 JO JOP/2020/0037A patent/JOP20200037A1/ar unknown
-
2021
- 2021-08-11 IL IL285526A patent/IL285526A/en unknown
- 2021-08-11 CL CL2021002111A patent/CL2021002111A1/es unknown
- 2021-08-13 CO CONC2021/0010751A patent/CO2021010751A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20220211837A1 (en) | 2022-07-07 |
| SG11202108766RA (en) | 2021-09-29 |
| KR20210129073A (ko) | 2021-10-27 |
| CL2021002111A1 (es) | 2022-01-28 |
| IL285526A (en) | 2021-09-30 |
| UY38587A (es) | 2020-09-30 |
| AR119691A1 (es) | 2022-01-05 |
| CA3130036A1 (fr) | 2020-08-20 |
| JOP20200037A1 (ar) | 2020-08-15 |
| MX2021009837A (es) | 2021-09-10 |
| TW202045205A (zh) | 2020-12-16 |
| PE20212322A1 (es) | 2021-12-14 |
| JP2022520443A (ja) | 2022-03-30 |
| BR112021016059A2 (pt) | 2021-10-13 |
| CO2021010751A2 (es) | 2021-09-09 |
| WO2020165912A1 (fr) | 2020-08-20 |
| EP3924052A1 (fr) | 2021-12-22 |
| CN113646047A (zh) | 2021-11-12 |
| AU2020222113A1 (en) | 2021-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA53544A (fr) | Procédé de préparation de compositions de vaccin | |
| CL2019003264A1 (es) | Formulaciones para vacunas contra la neoplasia y métodos para preparar las mismas. (divisional solicitud 201703151) | |
| BR112016006326A2 (pt) | formulação seca de uma vacina, uso de uma formulação seca, método para fabricação de uma formulação seca, e, vacina | |
| PH12017501370A1 (en) | Bivalent swine influenza virus vaccine | |
| DK3068392T3 (da) | Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til behandlingen af cftr-medierede sygdomme | |
| SG11202001161YA (en) | Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus chikv-delta5nsp3 | |
| BR112017019728A2 (pt) | combinações e formulações de dose fixa compreendendo etc1002 e uma ou mais estatinas e método para tratar ou reduzir o risco de doença cardiovascular | |
| MA45381A (fr) | Formulation de vaccin contre le vih | |
| GB2539148A (en) | Vaccine compositions | |
| PH12017500003A1 (en) | Vaccine composition for classical swine fever from plant and manufacturing method thereof | |
| BR112017019358A2 (pt) | combinações e formulações de dose fixa compreendendo etc1002 e ezetimiba e métodos de tratamento ou redução do risco de doença cardiovascular | |
| EP3280422A4 (fr) | Compositions et méthodes de traitement d'une infection à vhb | |
| EP3773709A4 (fr) | Procédés de génération de compositions de vaccin largement protectrices comprenant de la neuraminidase | |
| EP3600396A4 (fr) | Composition vaccinale d'acide nucléique comprenant une formulation lipidique, et procédé permettant d'augmenter l'efficacité de vaccins d'acide nucléique | |
| MA49472A (fr) | Procédé de préparation d'intermédiaire de dérivé de 4-méthoxypyrrole | |
| BR112019007858A2 (pt) | formulações farmacêuticas e métodos para produzir as mesmas | |
| MA51060A (fr) | Formulations de compositions de vaccin contre le virus de la dengue | |
| EA201790275A1 (ru) | Кристаллические формы 6-((6,7-диметоксихиназолин-4-ил)окси)-n,2-диметилбензофуран-3-карбоксамида | |
| PH12016502039A1 (en) | Potent and selective inhibitors of hepatitis c virus | |
| CO2021009379A2 (es) | Formulaciones y métodos de la vacuna contra el norovirus | |
| MX340098B (es) | Derivados de fenil-isoxazol y procedimiento para la preparacion de los mismos. | |
| IL308194A (en) | Immunogenic composition against influenza | |
| MA51307A (fr) | Compositions laitières fermentées et procédés de préparation de celles-ci | |
| EP3305328A4 (fr) | Composition protectrice de vaccin non gélatineuse et vaccin contre la grippe vivant atténué | |
| BR112018076734A2 (pt) | compostos heterocíclicos anti-infecciosos e usos dos mesmos |